Most Active Healthtech Investors in New York 2026

15 firms writing Healthtech checks in New York, led by General Catalyst, Social Starts, Andreessen Horowitz — ranked by verified deal count.

Healthtech in New York accounts for 35 tracked companies with verified cap-table data, 35 of which disclose round sizes totalling $6.7B. The median disclosed raise is $105M, and the largest is Ro at $1B, ahead of Abridge ($758M) and Judi Health ($607M).

The names that recur most often on these healthtech cap tables are General Catalyst (4 companies), Andreessen Horowitz (4 companies), Transformation Capital (4 companies), TCV (3 companies), Optum Ventures (3 companies), FirstMark Capital (2 companies). By latest disclosed round, the market skews Series C (11), Series B (9), Series D (7), Series A (4).

Best funded Healthtech in New York companies

  1. Ro — $1B (latest: Series D)
  2. Abridge — $758M (latest: Series D)
  3. Judi Health — $607M (latest: Series F)
  4. K Health — $439M (latest: Series F)
  5. Maven Clinic — $425M (latest: Series D)
  6. Spring Health — $400M (latest: Series E)
  7. Grow Therapy — $225M (latest: Series D)
  8. Nitra — $205M (latest: Series B)
  9. Garner Health — $200M (latest: Series D)
  10. Nomad Health — $200M (latest: Series D)
  11. Unite Us — $195M (latest: Series C)
  12. Empathy — $162M (latest: Series C)
  13. Tennr — $162M (latest: Series C)
  14. Midi Health — $160M (latest: Series D)
  15. Vi Labs — $158M (latest: Growth)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library